Matches in Wikidata for { <http://www.wikidata.org/entity/Q93071575> ?p ?o ?g. }
- Q93071575 description "article scientifique publié en 2019" @default.
- Q93071575 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q93071575 description "scientific article published on 27 June 2019" @default.
- Q93071575 description "wetenschappelijk artikel" @default.
- Q93071575 description "наукова стаття, опублікована 27 червня 2019" @default.
- Q93071575 name "Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial" @default.
- Q93071575 name "Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial" @default.
- Q93071575 type Item @default.
- Q93071575 label "Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial" @default.
- Q93071575 label "Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial" @default.
- Q93071575 prefLabel "Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial" @default.
- Q93071575 prefLabel "Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial" @default.
- Q93071575 P1433 Q93071575-74D7D696-BC1A-4ADF-96E4-DD5E4FAEEC76 @default.
- Q93071575 P1476 Q93071575-30107FDD-0AB3-430C-8537-F6657B4CF715 @default.
- Q93071575 P2093 Q93071575-0B6EC096-46FF-46BB-8345-239514EE122D @default.
- Q93071575 P2093 Q93071575-0B85111F-7DAF-4888-9EE8-77CB1DA1EAC6 @default.
- Q93071575 P2093 Q93071575-0EA5D951-0594-44D7-8510-44A62A31D346 @default.
- Q93071575 P2093 Q93071575-175898A2-825A-4585-8F5C-BB6D937544DF @default.
- Q93071575 P2093 Q93071575-208FCEFB-9061-40FC-A41B-D8381502E0F4 @default.
- Q93071575 P2093 Q93071575-24D70D03-0680-40FF-8A76-264653A6BF47 @default.
- Q93071575 P2093 Q93071575-45BD1617-B1D7-4462-9179-CD1090690C0A @default.
- Q93071575 P2093 Q93071575-5525ECE3-2D97-4266-9CBA-1BF1F6DFE9C0 @default.
- Q93071575 P2093 Q93071575-94FEB69C-75B7-49D3-B75C-412EE686677C @default.
- Q93071575 P2093 Q93071575-B443F9B7-7A6B-4F0A-9E42-781CE99C1397 @default.
- Q93071575 P2093 Q93071575-B4CC2E46-53A0-494A-8562-1648873B4DFB @default.
- Q93071575 P2093 Q93071575-B927B82A-A420-494B-BF68-481800695F95 @default.
- Q93071575 P2093 Q93071575-E050AC4D-8420-4F8D-9805-F03519DCD68E @default.
- Q93071575 P2860 Q93071575-1693702E-9C37-406C-9BFD-00F93CF35FD4 @default.
- Q93071575 P2860 Q93071575-2BDBFD74-33B5-4D28-9B0B-B73B043ED3BE @default.
- Q93071575 P2860 Q93071575-318867EA-5F4C-4AC2-98A8-BF6FE805FD7F @default.
- Q93071575 P2860 Q93071575-4DD35369-C6AA-4189-84C5-C1E4A67EA315 @default.
- Q93071575 P2860 Q93071575-84417A74-3167-4296-82EC-6ACD74E8E76F @default.
- Q93071575 P2860 Q93071575-8FA33726-FD29-431F-BE6C-17FAD543AE2F @default.
- Q93071575 P2860 Q93071575-A665426B-4F1C-460E-842F-9B8ED058FE4F @default.
- Q93071575 P2860 Q93071575-B54B340B-95BA-4A51-B1AF-2076EA83C599 @default.
- Q93071575 P2860 Q93071575-B70B1D73-2F21-499C-B828-AAB5310F8754 @default.
- Q93071575 P2860 Q93071575-B75089E6-5B69-4559-B242-F5613CB473DE @default.
- Q93071575 P2860 Q93071575-C73777F0-3393-44E4-813F-4FA7EBFC8EC7 @default.
- Q93071575 P2860 Q93071575-D64B6926-133D-4EAC-9322-DBBBABDB5A20 @default.
- Q93071575 P2860 Q93071575-F10AF7C5-CC29-44AF-829C-0CCBCC381669 @default.
- Q93071575 P2860 Q93071575-F2BC39D7-5C52-4E45-B3E0-D570A204C0F3 @default.
- Q93071575 P2860 Q93071575-F4A39620-1D70-4A37-870A-001193D3F726 @default.
- Q93071575 P2860 Q93071575-F96F6518-BCE4-47D7-A201-57F577F725E7 @default.
- Q93071575 P304 Q93071575-4290DA2E-658C-4C3E-9B57-9DDEC2526746 @default.
- Q93071575 P31 Q93071575-C912ED94-4A0A-4A18-8A62-D95EA544BA22 @default.
- Q93071575 P356 Q93071575-B622A83C-E0BE-4B94-A8ED-3176B20975CB @default.
- Q93071575 P433 Q93071575-F3AD3D67-F1D7-4FA4-BA86-C6702592C939 @default.
- Q93071575 P478 Q93071575-4EB1FD05-DC26-4BCF-9D29-C8BC12BBE237 @default.
- Q93071575 P50 Q93071575-57746B9D-DF5F-4DF2-96E7-EDE4E6182392 @default.
- Q93071575 P50 Q93071575-82C49DBF-F519-47E6-A246-61F66E2325CA @default.
- Q93071575 P50 Q93071575-9EA0A275-387A-4FD9-A339-3EBFF271056E @default.
- Q93071575 P50 Q93071575-C7A111EF-860B-4BC0-B805-4DE1BBE49929 @default.
- Q93071575 P50 Q93071575-E61E0E05-7023-4B2B-9DC8-B607A7944C8D @default.
- Q93071575 P577 Q93071575-72FDCDED-6B2E-44CA-B4F9-71FECEC7C4CB @default.
- Q93071575 P698 Q93071575-DD04CBEE-DB29-4740-8968-FCCBE1704A86 @default.
- Q93071575 P921 Q93071575-9A894234-7D4D-47D9-AE37-412740B7CA35 @default.
- Q93071575 P921 Q93071575-D6E9671F-C44A-4B09-9F0D-1BF226D8AA1A @default.
- Q93071575 P921 Q93071575-F0403DF6-465B-401A-AD0E-B7DFDE70D37F @default.
- Q93071575 P932 Q93071575-22D47396-9F79-4C9A-B554-910BDC8D2440 @default.
- Q93071575 P356 CNCR.32190 @default.
- Q93071575 P698 31246283 @default.
- Q93071575 P1433 Q326041 @default.
- Q93071575 P1476 "Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial" @default.
- Q93071575 P2093 "A Dimitrios Colevas" @default.
- Q93071575 P2093 "Fernando Concha-Benavente" @default.
- Q93071575 P2093 "Francis Worden" @default.
- Q93071575 P2093 "Jerome Fayette" @default.
- Q93071575 P2093 "Joel Guigay" @default.
- Q93071575 P2093 "Kevin J Harrington" @default.
- Q93071575 P2093 "Li Li" @default.
- Q93071575 P2093 "Lisa Licitra" @default.
- Q93071575 P2093 "Makoto Tahara" @default.
- Q93071575 P2093 "Mark Lynch" @default.
- Q93071575 P2093 "Robert Haddad" @default.
- Q93071575 P2093 "Stefan Kasper" @default.
- Q93071575 P2093 "Vijayvel Jayaprakash" @default.
- Q93071575 P2860 Q28131668 @default.
- Q93071575 P2860 Q28265610 @default.
- Q93071575 P2860 Q30048279 @default.
- Q93071575 P2860 Q37088281 @default.
- Q93071575 P2860 Q37350763 @default.
- Q93071575 P2860 Q38374778 @default.
- Q93071575 P2860 Q38378068 @default.
- Q93071575 P2860 Q38391922 @default.
- Q93071575 P2860 Q38748974 @default.
- Q93071575 P2860 Q39232473 @default.
- Q93071575 P2860 Q43164702 @default.
- Q93071575 P2860 Q50003965 @default.
- Q93071575 P2860 Q50089384 @default.
- Q93071575 P2860 Q59359495 @default.
- Q93071575 P2860 Q83980808 @default.
- Q93071575 P2860 Q88984927 @default.
- Q93071575 P304 "3208-3218" @default.
- Q93071575 P31 Q13442814 @default.
- Q93071575 P356 "10.1002/CNCR.32190" @default.
- Q93071575 P433 "18" @default.
- Q93071575 P478 "125" @default.
- Q93071575 P50 Q107015339 @default.
- Q93071575 P50 Q38328358 @default.
- Q93071575 P50 Q61157874 @default.